Tampere University Hospital is a teaching hospital of Tampere University along Teiskontie at the Kauppi district in Tampere, Finland.

There are 1,000 beds in Tampere University Hospital; Hematology.

During the past decade, Tampere University Hospital; Hematology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tampere University Hospital; Hematology" #1 collaborator was "NordForsk" with 2 trials as a collaborator, "The Swedish Childhood Cancer Foundation" with 2 trials as a collaborator, "Aamu Pediatric Cancer Foundation" with 1 trials as a collaborator, "Acreditar - Associação de Pais e Amigos das Crianças com Cancro" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Tampere University Hospital; Hematology" are "Leukemia, Acute Lymphoblastic" (2 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Leukemia, Myeloid, Acute" (1 trials). Many other conditions were trialed in "Tampere University Hospital; Hematology" in a lesser frequency.

Most popular intervention types in "Tampere University Hospital; Hematology" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "6-tioguanine+Standard Maintenance Therapy" (1 trials), "Bendamustine" (1 trials), "Blinatumomab" (1 trials), "Chlorambucil" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tampere University Hospital; Hematology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Tampere University Hospital; Hematology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Tampere University Hospital; Hematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tampere University Hospital; Hematology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".